| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
2,312.70
|
|
Change (%)
|
-22.25 (-0.95%)
|
|
Best Buy (RS)
|
0(x0)
|
|
Best Sell (RS)
|
0(x0)
|
|
Today's Range (RS)
|
2,295.70
-
2,333.85
|
|
52-Week Range (RS)
|
1,774.00
-
2,376.00
|
|
Beta (1 Year)
|
0.74
|
|
|
|
|
|
| Index Details |
| BSE 100, BSE 500, BSE 200, BSE HC, BSE DOLLEX, BSE Shariah 50, bse carbonex |
| News |
|
Corporate Details |
| Lupin slips as Ankleshwar facility gets two observations from US FDA |
| Lupin receives EIR report with VAI classification for its Goa unit |
| Lupin gets satisfactory USFDA inspection report for Goa facility |
| Lupin gets USFDA nod for Brivaracetam Oral Solution |
| Lupin receives USFDA approval for Brivaracetam Oral Solution 10 mg/mL |
| Lupin Ltd spurts 1.61% |
| Lupin secures European Commission approval for Ranluspec |
| Lupin receives European Commission approval for Biosimilar Ranibizumab |
| Stock Alert: Lupin, NTPC, Cochin Shipyard, Texmaco Rail & Engineering, BLS E-Services |
| Lupin rises on licensing pact with Spektus Pharma for DeslaFlex in Canada |
|
|
|
| Incoporation Year : 1983 |
| Chairman : M D Gupta |
| Ownership Group : Indian Private |
| Sector : MAN |
| Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |
| Registered Office |
Lupin Ltd
Kalpataru Inspire 3rd Floor,
Off Western Exp HW Santacruz-E,
Mumbai,
Maharashtra-400055 |
Phone:91-22-6640 2323
Fax:91-22-6640 8131 |
| E-Mail : investorservices@lupinpharma.com |
URL : https://www.lupin.com
|
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
23-Mar-2026 |
2297.20 |
0.67 |
| 1Month |
02-Mar-2026 |
2311.60 |
0.05 |
| 3Month |
30-Dec-2025 |
2081.00 |
11.13 |
| 6Month |
30-Sep-2025 |
1910.15 |
21.07 |
| 1Year |
01-Apr-2025 |
1956.40 |
18.21 |
|
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| HDFC Balanced Advantage Fund |
1.22 |
1308.97 |
| HDFC Large Cap Fund |
2.65 |
1062.55 |
| Mirae Asset Large & Midcap Fund |
2.35 |
1010.11 |
| HDFC Flexi Cap Fund |
0.96 |
966.80 |
| Nippon India Pharma Fund |
7.99 |
663.87 |
|
|
|
|
| Groups : Pharmaceuticals - Indian - Bulk Drugs & Formln |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Sun Pharmaceutical Industries Ltd |
1,757.35 |
-2.13 |
1,850.95 |
1,547.25 |
421,647.13 |
| Dr Reddys Laboratories Ltd |
1,254.65 |
-2.13 |
1,377.95 |
1,025.90 |
104,720.24 |
| Cipla Ltd |
1,223.05 |
-1.58 |
1,672.20 |
1,215.65 |
98,795.85 |
| Zydus Lifesciences Ltd |
871.20 |
-2.83 |
1,059.00 |
797.05 |
87,663.11 |
| Mankind Pharma Ltd |
2,005.85 |
-1.69 |
2,726.75 |
1,909.90 |
82,807.17 |
|
|
|
|